"This is about starting the data story at the source," said Charles Hutka, Chief Commercial Officer at StafaCT. "When apheresis data is captured directly -- across both collection and therapeutic ...
CHICAGO, April 12, 2024 /PRNewswire/ -- Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results